Skip to Main Content
Contribute Try STAT+ Today

Surprise diagnoses have a way of making Ph.D. candidates out of everyday people.

Walter Feigenson’s education began in 2007, at age 59, when he was wrongly diagnosed with congestive heart failure. Then came carpal tunnel syndrome, which doctors chalked up to his years in front of a keyboard. In 2010 it was a ruptured bicep tendon, and in 2015 a case of a spinal condition called lumbar stenosis. It wasn’t until 2018, when “dumb luck” landed Feigenson in front of a specialist at Oregon Health and Science University, that someone connected the dots between his disparate symptoms: He had a progressive disease that was destroying his heart.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment